These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 8653991

  • 21. Salivary clearance and urinary metabolic pattern of caffeine in healthy children and in pediatric patients with hepatocellular diseases.
    el-Yazigi A, Shabib S, al-Rawithi S, Yusuf A, Legayada ES, al-Humidan A.
    J Clin Pharmacol; 1999 Apr; 39(4):366-72. PubMed ID: 10197295
    [Abstract] [Full Text] [Related]

  • 22. Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis.
    Lelouët H, Bechtel YC, Paintaud G, Brientini MP, Miguet JP, Bechtel PR.
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):25-32. PubMed ID: 11204934
    [Abstract] [Full Text] [Related]

  • 23. Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.
    Fuhr U, Rost KL.
    Pharmacogenetics; 1994 Jun; 4(3):109-16. PubMed ID: 7920690
    [Abstract] [Full Text] [Related]

  • 24. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT, Zocchetti C, Bernucci I, Kadlubar FF, Tannenbaum S, Skipper P, Bartsch H, Malaveille C, Shields P, Caporaso NE, Vineis P.
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.
    Takata K, Saruwatari J, Nakada N, Nakagawa M, Fukuda K, Tanaka F, Takenaka S, Mihara S, Marubayashi T, Nakagawa K.
    Eur J Clin Pharmacol; 2006 Jan; 62(1):23-8. PubMed ID: 16385402
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cytochrome P450 2A6 Phenotyping Using Dietary Caffeine Salivary Metabolite Ratios and Genotyping Using Blood on Storage Cards in Non-smoking Japanese Volunteers.
    Murayama N, Shimizu M, Kobayashi K, Kishimoto I, Yamazaki H.
    Drug Metab Lett; 2017 Jan; 10(4):240-243. PubMed ID: 27842485
    [Abstract] [Full Text] [Related]

  • 35. Impact of long-term ethanol consumption on CYP1A2 activity.
    Rizzo N, Hispard E, Dolbeault S, Dally S, Leverge R, Girre C.
    Clin Pharmacol Ther; 1997 Nov; 62(5):505-9. PubMed ID: 9390106
    [Abstract] [Full Text] [Related]

  • 36. Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.
    Granfors MT, Backman JT, Laitila J, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 Oct; 78(4):400-11. PubMed ID: 16198659
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.